Novel First-in-Class Drug ONC201 As a Post-Transplant Maintenance for AML and MDS: A Phase I Trial in ProgressVijaya Raj Bhatt,Christopher Wichman,Alyssa C. Bouska,Lori Maness,Zaid S. Al-Kadhimi,Javeed Iqbal,James E. Talmadge,Krishna GundaboluBlood(2022)引用 0|浏览15暂无评分关键词aml,first-in-class,post-transplantAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要